Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Asset Utilization Ratio: 2015-2025

Historic Asset Utilization Ratio for Zevra Therapeutics (ZVRA) over the last 10 years, with Sep 2025 value amounting to 0.32.

  • Zevra Therapeutics' Asset Utilization Ratio rose 119.95% to 0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32, marking a year-over-year increase of 119.95%. This contributed to the annual value of 0.13 for FY2024, which is 29.42% down from last year.
  • As of Q3 2025, Zevra Therapeutics' Asset Utilization Ratio stood at 0.32, which was up 10.93% from 0.29 recorded in Q2 2025.
  • Over the past 5 years, Zevra Therapeutics' Asset Utilization Ratio peaked at 0.46 during Q1 2021, and registered a low of 0.08 during Q2 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.16 (2024), whereas its average is 0.18.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 87.97% in 2021, then spiked by 119.95% in 2025.
  • Over the past 5 years, Zevra Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.21 in 2021, then crashed by 59.21% to 0.09 in 2022, then spiked by 103.92% to 0.18 in 2023, then dropped by 27.67% to 0.13 in 2024, then surged by 119.95% to 0.32 in 2025.
  • Its Asset Utilization Ratio stands at 0.32 for Q3 2025, versus 0.29 for Q2 2025 and 0.23 for Q1 2025.